logo
logo
Sign in

Hydroxychloroquine Market 2021 Size & Share | Market worth USD 2339.1 million with 5.5% CAGR by 2027

avatar
saurabh jadhav
Hydroxychloroquine Market 2021 Size & Share | Market worth USD 2339.1 million with 5.5% CAGR by 2027

The global “Hydroxychloroquine Market” is projected to reach USD 2,339.1 million by the end of 2027. The increasing incidence of COVID-19 infection will bode well for the market in the coming years.

According to a report published by Fortune Business Insights, titled “Hydroxychloroquine Market Size, Share & Industry Analysis, By Disease Indication (Malaria, COVID-19, Rheumatoid Arthritis, Others), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Stores), and Regional Forecast, 2020-2027,” the market was worth USD 894.0 million in 2019 and will exhibit a CAGR of 5.5% during the forecast period, 2020-2027.

Hydroxychloroquine is a drug that is used for treatment of patients suffering from malaria. The drug was initially prescribed for use by leading authorities such as the EU and the Food and Drug Administration for treatment of patients suffering from arthritis as well as autoimmune diseases such as lupus. The ongoing coronavirus outbreak has led to a huge emphasis on the research and development of several drugs associated with its treatment. It was observed that hydroxychloroquine showed positive signs in recovery phase of patients suffering from the coronavirus. As a result, there is a sudden surge in demand for the product across the world. Countries such as the United States are putting in several efforts to development an efficient treatment option with the help of hydroxychloroquine. The increasing cases of malaria will create several growth opportunities for the companies operating in the market. The growing demand for the product across the world will have a positive impact on the growth of the overall market in the coming years.

Major Hydroxychloroquine Market Key players covered in the report include:

  • Sanofi
  • Zydus Cadia
  • Ipca Laboratories Ltd
  • Sandoz International GmbH (part of Novartis AG)
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd
  • Bayer AG
  • Others in the report

Get Request a Sample Copy of the Hydroxychloroquine Report:

https://www.fortunebusinessinsights.com/hydroxychloroquine-market-102706

Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for market to figure out and study the market’s needs, market size, and competition.

Hydroxychloroquine Market Analysis 2021:

Increasing Efforts Taken to Maximize the Production Will Aid Market Growth

The report encompasses several factors that have contributed to the growth of the market in recent years. The ability of hydroxychloroquine to speed up recovery processes in treatment of patients suffering from diseases such as malaria and rheumatoid arthritis has contributed to the growing demand for the product. The increasing product demand has encouraged several companies to enhance their production methods as well as capabilities associated with the product. The report labels several companies that have taken several steps to increase the production of hydroxychloroquine during the coronavirus pandemic. In April 2020, Zydus Caadila announced that it has scaled up the production of hydroxychloroquine. The company was encouraged by the sudden rise in the demand for the product; a factor that was consequential to the constantly rising Covid-19 cases across the world. Zydus’ latest step will have a huge impact on the growth of the overall market in the coming years.

For More Information in the Analysis of Reports: 

https://www.fortunebusinessinsights.com/hydroxychloroquine-market-102706

collect
0
avatar
saurabh jadhav
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more